Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Eli Lilly (NY: LLY )

212.35 USD +6.21 (+3.01%)
Official Closing Price Updated: 5:36 PM EST, Jan 25, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Stories about Eli Lilly

< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Stocks Reach Euphoria As Election Hedges Unwind
The stock market reached a euphoric stage on Thursday. On Wednesday, tech dominated the market. On Thursday, small caps joined the fun in what could only be described as extreme euphoria. 
Tags Stocks / Equities
From Blogs - TalkMarkets
Investors Cheer Gridlock Potential That Could Prevent Tax, Tech, Health Care Overhauls
It’s often been said that the stock market dislikes uncertainty. So it may be a little bit of a surprise that the market rally is ... 
Tags Facebook News General
From Benzinga
Signs point to FDA approval for Biogen’s experimental Alzheimer’s disease treatment, though there are skeptics
Odds are increasing that Biogen’s experimental and somewhat controversial Alzheimer’s disease drug may get approved after Food and Drug Administration officials said there was enough evidence in... 
Tags Biotechnology Pharmaceuticals Health/Care
From MarketWatch
Incyte Earnings Miss Expectations; Tightens Outlook For Top Product
Incyte early Thursday posted earnings that fell well short of Wall Street expectations, and revenue that narrowly missed views, and INCY stock slipped early following a big jump Wednesday. 
From Investor's Business Daily
51 Biggest Movers From Yesterday
Gainers Aptevo Therapeutics Inc. (NASDAQ: APVO) shares jumped 51.2% to close at $16.98 on Wednesday. Aptevo Therapeutics, on ... 
Tags ACIU TA HY
From Benzinga
These stocks rose the most Wednesday as investors cheered a divided government following the elections
The Nasdaq Composite Index jumped 3.9%, led by tech and health-care stocks. 
Tags BA Internet Software General
From MarketWatch
Why Eli Lilly's Stock Is Trading Higher Today
Eli Lilly (NYSE: LLY) shares are trading higher on Wednesday. The strength is potentially in sympathy with Biogen(NASDAQ: BIIB) ... 
Tags LLY Benzinga why it's moving
From Benzinga
Notable Wednesday Option Activity: LLY, WYNN, PAYC
Looking at options trading activity among components of the S&P 500 index, there is noteworthy activity today in Lilly (Eli) & Co (LLY), where a total volume of 29,957 contracts has been traded thus... 
Tags Stocks
From Market News Video
40 Stocks Moving In Wednesday's Mid-Day Session
Gainers Biogen Inc. (NASDAQ: BIIB) shares jumped 40.6% to $347.39 after FDA briefing documents showed company provided evidence of ... 
Tags AMWL Mid/Day Movers THMO
From Benzinga
MTUM, LLY, AMGN, BMY: Large Outflows Detected at ETF
Symbols mentioned in this story: MTUM, LLY, AMGN, BMY Exchange traded funds (ETFs) trade just like stocks, but instead of ''shares'' investors are actually buying and selling ''units''. These ''units''... 
Tags ETFs
From ETF Channel
Instead of Chasing Every New Vaccine "Breakthrough," Trade the Whole Sector
As the pandemic continues to rage on, so does the race to develop a vaccine. But not every biotech company is doing well in the search for an effective vaccine or treatment. 
Tags Pharma/Biotech Stocks / Equities ETFs
From Blogs - TalkMarkets
Why Regeneron Is Halting Coronavirus Antibody Cocktail Study Enrollment In Patients With Severe Cases
Regeneron Pharmaceuticals Inc (NASDAQ: REGN) faced a setback Friday in a trial evaluating its antibody cocktailREGN-COV2in ... 
Tags Market News Benzinga Coronavirus
From Benzinga
Why Eli Lilly is a Top 25 Dividend Giant (LLY)
Lilly (Eli) & Co (LLY) has been named as a Top 25 ''Dividend Giant'' by ETF Channel, with a staggering $11854205.03B worth of stock held by ETFs, and above-average ''DividendRank'' statistics including... 
Tags ETFs
From ETF Channel
IBD 50 Stocks To Watch: Pharma That Treated Trump Is Building Base
Regeneron Pharmaceuticals is the IBD 50 Stocks To Watch pick for Thursday as it gets set to build a bullish base. 
From Investor's Business Daily
Gilead unexpectedly cashes in with nearly $900 million in sales of COVID-19 drug
Gilead Sciences Inc.’s prominent COVID-19 drug unexpectedly brought in $100 more million in sales than analysts had expected in the third quarter, but that doesn’t mean Wall Street’s questions about... 
Tags Pharmaceuticals Biotechnology Earnings
From MarketWatch
Coronavirus update: U.S. continues to set new case records and Trump remains insistent that U.S. has ‘rounded the corner’
The U.S. death toll from the coronavirus illness COVID-19 edged closer to 228,000 on Thursday and more than 81,000 new infections were recorded in a single day, pushing the seven-day tally to record... 
Tags TAP Company Announcements/Warnings Company Announcements
From MarketWatch
Regeneron Posts Positive Data For Covid-19 Treatment; Lung Cancer Drug Advances
Regeneron Pharmaceuticals late Wednesday posted positive clinical trials data on its Covid-19 treatment and Thursday said a lung cancer drug received FDA priority review. Regeneron stock rose. 
From Investor's Business Daily
Regeneron Says COVID-19 Antibody Cocktail Reduced Viral Load, Need For Medical Care In Late-Stage Trial
Regeneron Pharmaceuticals, Inc (NASDAQ: REGN) said Wednesday data from late-stage clinical trials is indicative that its antibody ... 
Tags Benzinga Coronavirus News
From Benzinga
Amgen Earnings, Sales Top Wall Street Views; Hikes Earnings Guidance
Amgen posted third-quarter earnings and sales that beat Wall Street views and hiked it earnings outlook, and Amgen stock rose after hours after hitting four-month lows in the regular session. 
From Investor's Business Daily
IWF, AMGN, LOW, LLY: ETF Outflow Alert
Symbols mentioned in this story: IWF, AMGN, LOW, LLY Exchange traded funds (ETFs) trade just like stocks, but instead of ''shares'' investors are actually buying and selling ''units''. These ''units''... 
Tags ETFs
From ETF Channel
Eli Lilly Inks Covid-19 Treatment Supply Deal With U.S. Despite Drug's Recent Failure
Eli Lilly inked a deal to sell up to 650,000 vials of its Covid-19 treatment candidate to the U.S., though the drug has failed a test in treating hospitalized patients. LLY stock slipped. 
From Investor's Business Daily
The Daily Biotech Pulse: Sanofi-GlaxoSmithKline To Supply 200M Doses To COVID-19 Vaccine Alliance, Gilead Earnings, Biodesix Debuts
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ... 
Tags MTCR NVS Earnings
From Benzinga
52 Biggest Movers From Yesterday
Gainers Scholar Rock Holding Corporation (NASDAQ: SRRK) shares jumped 118.8% to close at $30.02 on Tuesday after the company ... 
Tags ISIG SPI GRTX
From Benzinga
After The Drop, Wait And See
After the huge global selloff yesterday, markets around the world are in wait-and-see mode overall, but reacting to real news when it hits. 
Tags Stocks / Equities Technology Pharma/Biotech
From Blogs - TalkMarkets
BofA On Eli Lilly: Disappointing Q3 Comes In Otherwise Strong 2020
Eli Lilly And Co’s (NYSE: LLY) third-quarter results show the persisting impact of COVID-19 and pricing headwinds, according to ... 
Tags Analyst Color Price Target Geoff Meacham
From Benzinga
Noteworthy Tuesday Option Activity: CSCO, LLY, GLW
Among the underlying components of the S&P 500 index, we saw noteworthy options trading volume today in Cisco Systems Inc (CSCO), where a total of 108,779 contracts have traded so far, representing... 
Tags Stocks
From Market News Video
46 Stocks Moving In Tuesday's Mid-Day Session
Gainers Scholar Rock Holding Corporation (NASDAQ: SRRK) gained 82.4% to $25.02 after the company reported proof-of-concept data ... 
Tags Intraday Update MCEP KNL
From Benzinga
Stocks Will Try To Advance On October 27
Stocks are rising on October 27, with the S&P 500 ETF trading higher by around 50 bps, making up for some of yesterday’s drop. 
Tags Stocks / Equities
From Blogs - TalkMarkets
Eli Lilly (LLY) Q3 Earnings And Revenues Miss Estimates
Eli Lilly came out with quarterly earnings of $1.54 per share, missing the Zacks Consensus Estimate of $1.76 per share. 
Tags Healthcare Stocks / Equities Pharma/Biotech
From Blogs - TalkMarkets
Caterpillar, Pfizer, 3M Earnings Come In Better Than Expected, With Microsoft Straight Ahead
After stumbling to start the week, it looks like Wall Street is trying to get back on its feet this morning. Major indices—which ... 
Tags TD Ameritrade General XLNX
From Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.